Amantadine in unvaccinated patients with early, mild to moderate COVID-19: a randomized, placebo-controlled, double-blind trial
Description
CONCLUSIONS: The central effects on the nervous system with reduction of sleepiness and depression might have had a supportive effect on faster recovery in early COVID-19 patients.
